(Q40897178)

24 September 2017

title

Increased endosomal sorting of ligand to recycling enhances potency of an interleukin-2 analog (English)

1 reference

24 September 2017

0 references

Fallon EM

1

1 reference

24 September 2017

Liparoto SF

2

1 reference

24 September 2017

Lee KJ

3

1 reference

24 September 2017

Ciardelli TL

4

1 reference

24 September 2017

Lauffenburger DA

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Journal of Biological Chemistry

24 September 2017

published in

1 reference

24 September 2017

volume

275

1 reference

24 September 2017

issue

10

1 reference

24 September 2017

page(s)

6790-6797

1 reference

Lymphocyte responses and cytokines

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Immune-mediated side-effects of cytokines in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Interleukin 2 and its receptors: recent advances and new immunological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Interleukin-2: inception, impact, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Aldesleukin (recombinant interleukin-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Recombinant interleukin-2 in cancer: basic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Effects of route and formulation on clinical pharmacokinetics of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

The role of low-affinity interleukin-2 receptors in autocrine ligand binding: alternative mechanisms for enhanced binding effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Molecular cloning of cDNA encoding human interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Several weak signals in the cytosolic and transmembrane domains of the interleukin-2-receptor beta chain allow for its efficient endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Endocytosis of the common cytokine receptor gammac chain. Identification of sequences involved in internalization and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

An alpha-helical signal in the cytosolic domain of the interleukin 2 receptor beta chain mediates sorting towards degradation after endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Design, synthesis and expression of a human interleukin-2 gene incorporating the codon usage bias found in highly expressed Escherichia coli genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Mutagenic analysis of a receptor contact site on interleukin-2: preparation of an IL-2 analog with increased potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Conformational perturbation of interleukin-2: a strategy for the design of cytokine analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Protein secondary structure and circular dichroism: a practical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Interleukin 2 high-affinity receptor expression requires two distinct binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Expression and ligand binding characterization of the beta-subunit (p75) ectodomain of the interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Kinetic analysis of ligand binding to interleukin-2 receptor complexes created on an optical biosensor surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Cell growth signal transduction is quantal

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Interleukin 2 regulates its own receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Engineering epidermal growth factor for enhanced mitogenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Intracellular receptor/ligand sorting based on endosomal retention components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Scratching the (cell) surface: cytokine engineering for improved ligand/receptor trafficking dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Ligand Binding Analysis of Soluble Interleukin-2 Receptor Complexes by Surface Plasmon Resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

A point mutation in interleukin-2 that alters ligand internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

IL-2 signalling in T and natural killer (NK) cells associated with their class I-non-restricted killing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.6790

21 January 2018

Identifiers

DOI

10.1074/JBC.275.10.6790

1 reference

24 September 2017

1 reference